Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather Ogana

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Mabs|April 5, 2021
TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHLHarbani K Malik-Chaudhry, Kirthana Prabhakar, Harshad S Ugamraj, et al.
Immunity|November 22, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Nature Communications|September 22, 2023
The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERGEitan Kugler, Shreyas Madiwale, Darren Yong, et al.
Cell Chemical Biology|October 29, 2021
Reprogramming CBX8-PRC1 function with a positive allosteric modulatorJunghyun L Suh, Daniel Bsteh, Bryce Hart, et al.
Cancer Discovery|March 5, 2026
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsJie Deng, Aastha Pal, Stefano Testa, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Mabs|April 5, 2021
TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHLHarbani K Malik-Chaudhry, Kirthana Prabhakar, Harshad S Ugamraj, et al.
Immunity|November 22, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Nature Communications|September 22, 2023
The NCOR-HDAC3 co-repressive complex modulates the leukemogenic potential of the transcription factor ERGEitan Kugler, Shreyas Madiwale, Darren Yong, et al.
Cell Chemical Biology|October 29, 2021
Reprogramming CBX8-PRC1 function with a positive allosteric modulatorJunghyun L Suh, Daniel Bsteh, Bryce Hart, et al.
Cancer Discovery|March 5, 2026
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsJie Deng, Aastha Pal, Stefano Testa, et al.
Pageof 2